| Donald P Glaser, MD | |
|
15 Southern Center Ct, Easley, SC 29642-1533 | |
| (864) 633-1053 | |
| (864) 343-2074 |
| Full Name | Donald P Glaser |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 20 Years |
| Location | 15 Southern Center Ct, Easley, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124236062 | NPI | - | NPPES |
| AA27767951 | Other | SC | GHS MEDICARE PTAN |
| 1124236062 | Other | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 30940 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clemson Eye Pa | 4183537764 | 46 |
News Archive
Researchers at Texas Biomedical Research Institute are zeroing in on a new way to target tuberculosis infection. The National Institutes of Health has awarded a four-year, $2.8 million grant for scientists to study the role of lung macrophages (immune cells) in metabolic and inflammation responses to TB.
Researchers in Australia have shown that a standard pasteurization method commonly used in human milk banks is effective at inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).
Stem cell therapies hold enormous potential to address some of the most tragic illnesses, diseases, and tissue defects world-wide. However, the inability to target cells to tissues of interest poses a significant barrier to effective cell therapy.
› Verified 1 days ago
| Entity Name | Clemson Eye Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447383831 PECOS PAC ID: 4183537764 Enrollment ID: O20031110000508 |
News Archive
Researchers at Texas Biomedical Research Institute are zeroing in on a new way to target tuberculosis infection. The National Institutes of Health has awarded a four-year, $2.8 million grant for scientists to study the role of lung macrophages (immune cells) in metabolic and inflammation responses to TB.
Researchers in Australia have shown that a standard pasteurization method commonly used in human milk banks is effective at inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).
Stem cell therapies hold enormous potential to address some of the most tragic illnesses, diseases, and tissue defects world-wide. However, the inability to target cells to tissues of interest poses a significant barrier to effective cell therapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald P Glaser, MD 15 Southern Center Ct, Easley, SC 29642-1533 Ph: (864) 633-1053 | Donald P Glaser, MD 15 Southern Center Ct, Easley, SC 29642-1533 Ph: (864) 633-1053 |
News Archive
Researchers at Texas Biomedical Research Institute are zeroing in on a new way to target tuberculosis infection. The National Institutes of Health has awarded a four-year, $2.8 million grant for scientists to study the role of lung macrophages (immune cells) in metabolic and inflammation responses to TB.
Researchers in Australia have shown that a standard pasteurization method commonly used in human milk banks is effective at inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).
Stem cell therapies hold enormous potential to address some of the most tragic illnesses, diseases, and tissue defects world-wide. However, the inability to target cells to tissues of interest poses a significant barrier to effective cell therapy.
› Verified 1 days ago
Dr. James Howard Oakman Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 109 Fleetwood Dr Ste B, Easley, SC 29640 Phone: 864-522-3970 Fax: 864-522-3975 | |
Allan James Thompson Jr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 109 Fleetwood Dr Ste B, Easley, SC 29640 Phone: 864-522-3970 Fax: 864-522-3975 | |
Dr. Brian Johnson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15 Southern Center Ct, Easley, SC 29642 Phone: 864-654-6706 | |
Michael Mequio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 220 S Pendleton St, Easley, SC 29640 Phone: 864-859-3233 Fax: 864-850-4001 | |
Dr. Joseph L Parisi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15 Southern Center Ct, Easley, SC 29642 Phone: 864-654-6706 Fax: 864-654-3275 | |
David M Bowden, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 220 S Pendleton St, Easley, SC 29640 Phone: 864-271-3354 |